http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104958295-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c930fe961268d7394c90bb17af774d58 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 |
filingDate | 2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad7c836f0a77948c65a63f148e9f59c0 |
publicationDate | 2015-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104958295-A |
titleOfInvention | Compound medicine composition for treating anaphylactic rhinitis |
abstract | The invention discloses a compound medicine composition for treating anaphylactic rhinitis. A preparation formulation of the compound medicine composition is oral pellicles. The formulation of the compound medicine composition mainly comprises effective ingredients as follows: desloratadine, zinc gluconate, a film-forming material, a filling agent, a plasticizer and a sweetening agent. A preparation method is simple and comprises the following steps of (1) weighing raw materials and auxiliary materials as follows: the desloratadine, the zinc gluconate, the film-forming material, the filling agent, the plasticizer, the sweetening agent and the like; (2) wetting the desloratadine by using the plasticizer, mixing the zinc gluconate, the film-forming material, the filling agent, the plasticizer and the sweetening agent in the desloratadine, adding solvent water in the mixture, uniformly stirring the mixture and standing; (3) adding appropriate essence and a color enhancing agent in the mixture after the mixture is swelled completely, uniformly stirring the mixture and standing for a period of time; and (4) coating the mixture and drying the mixture to obtain the compound medicine composition. The compound medicine composition for treating the anaphylactic rhinitis tastes good, a patient does not need to drink water when orally taking the compound medicine composition, and medication compliance of the patient is improved; and the compound medicine composition can be dissolved quickly in the oral cavity of the patient, parts of medicines can be absorbed by oral mucosa of the patient, and a first-pass effect and gastrointestinal tract side effects are avoided to a certain degree. Moreover, the preparation method of the compound oral water-soluble film is simple, consumed time is short, and the cost is low. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106619577-A |
priorityDate | 2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.